Professor Norman Noah Editor-in-Chief
Norman is an infectious disease epidemiologist. After initially specialising in general medicine, and gaining a specialist degree (MRCP), he ‘saw the light’ and moved specialities to infectious disease epidemiology. He worked as a Consultant Infectious Disease Epidemiologist in the Communicable Disease Surveillance Centre at the Public Health Laboratory Service (now Public Health England) from 1977 to 1989 and gained extensive experience in outbreak investigation, vaccine studies, and surveillance of infectious disease. He also conducted research and teaching, and had several papers, reviews and editorials published in international medical journals, as well as chapters in books. He has written a textbook titled ‘Controlling Communicable Disease’ which was commissioned by the Open University and published by McGraw. He has also edited other books and contributed chapters to books.
He was appointed Professor of Epidemiology and Public Health at Kings College School of Medicine and Dentistry and ran the department there from 1989-98. He is now Professor Emeritus of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine and has been editing Epidemiology and Infection since 2002.
Michael Edelstein Deputy Editor
Michael Edelstein is a medical doctor specialised in public health, with expertise in vaccine epidemiology, surveillance systems and outbreak investigations, in both routine and emergency contexts. He works at Public Health England’s immunisation department where his focus is on vaccine coverage data, hepatitis A and HPV. He is also a research fellow at Chatham House’s Centre on Global health Security, a fellow of the Faculty of Public health at the Royal College of Physicians (London) and an honorary associate professor at London School of Hygiene and Tropical Medicine (London). Michael has worked at national public health agencies and international organisations in Europe, Africa and Southeast Asia.
Lisa Bebell Associate Editor
Massachusetts General Hospital in Boston, USA. After completing residency training in internal medicine, she specialized in infectious diseases and critical care medicine. Currently, Lisa devotes the majority of her time to clinical research. In partnership with local researchers in Uganda, Lisa carries out translational and epidemiology research projects on pregnancy-related infections. Her current work focuses on the placenta as a mediator of poor outcomes in HIV-exposed infants and the placenta's role in early-life immunulogic outcomes. Lisa has published manuscripts on filovirus infections in pregnancy, antimicrobial resistance, and epidemiology of maternal and neonatal sepsis in resource-limited settings.Bebell is a medical doctor affiliated with Harvard Medical School and
Paolo Bonanni Associate Editor
Dr Bonanni is professor of Hygiene in the Faculty of Medicine, University of Florence, Italy, and Director of the Specialization School in Hygiene and Preventive Medicine at the University of Florence.
His scientific activity has covered the epidemiology and prevention of infectious diseases, particularly viral hepatitis, diphtheria, tetanus, pertussis, influenza, measles, rubella, varicella, and, most recently, bacterial invasive diseases and human papilomavirus (HPV), including clinical trials and economic evaluation of vaccination strategies. He has been responsible for a research unit in European Union funded projects on antibiotic resistance, surveillance of vaccine-preventable hepatitis, vaccine safety and screening and treatment of migrants for hepatitis B and C.
He was a member of the National Vaccination Commission of the Italian Ministry of Health between 2007 and 2008, and has acted as an expert consultant for the European Centre for Disease Prevention and Control (ECDC). He was also a member of the European Technical Advisory Group of Experts (ETAGE) at WHO-Euro between 2012 and2017, and he still collaborates with WHO on specific topics.
He is a standing adviser of the Viral Hepatitis Prevention Board (VHPB) and Director of the University of Florence Post-Graduate Course on 'Vaccines and Vaccination Strategies', established in 2001.
Lisa Boden Associate Editor
Lisa Boden is a UK (RCVS) and European veterinary specialist in veterinary public health & population medicine with a PhD in veterinary epidemiology and a Masters of Laws in medical law and ethics. She is currently a senior lecturer at the University of Edinburgh, at the Global Academy of Agriculture and Food Security and is Deputy Director and Principal investigator of EPIC (Scottish Government’s Centre for Expertise in Animal Disease Outbreaks). EPIC’s mission is to provide policymakers with rapid access to emergency scientific advice and analyses to prepare for and respond to emergency exotic and novel animal disease outbreaks.
Lisa’s work includes translation and communication of science as effective and ethical evidence for policy, contingency planning and emergency outbreak response and management, risk assessment and communication and horizon scanning and scenario planning work to facilitate strategic thinking about risk and long-term future resilience to disease outbreaks.
Lisa is also a Council Member and Chair of the Credentials Committee of the European College of Veterinary Public Health which is responsible for resident training/ knowledge exchange to promote integrated, multidisciplinary approaches towards improving human and animal public health.
Andrew Breed Associate Editor
Andrew is a veterinary epidemiologist at the Australian government’s Department of Agriculture and Water Resources and Honorary Associate Professor at the University of Queensland’s School of Veterinary Science.
His research interests include wildlife disease epidemiology, viral zoonoses, animal disease surveillance and phylogenetics. He has extensive experience working on avian influenza and viral zoonoses of bats in Australia, Europe, Asia and Africa. He worked for eight years at the Animal and Plant Health Agency in the UK following completing a PhD with the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease. He is a Diplomat of the European College of Zoological Medicine and recognised veterinary specialist in Wildlife Population Health.
Laura Gieraltowski Associate Editor
Dr. Laura Gieraltowski is the Lead of the Foodborne Outbreak Response Team in the Outbreak Response and Prevention Branch at the Centers for Disease Control and Prevention in Atlanta, Georgia. She leads the team that helps coordinate the national network of epidemiologists and other public health officials who investigate outbreaks of foodborne and other enteric illnesses. Dr. Gieraltowski is a graduate of CDC's Epidemic Intelligence Service Program. She received a PhD in Epidemiology from the University of Pittsburgh Graduate School of Public Health and has a Masters of Public Health degree in behavioral health sciences from Emory University Rollins School of Public Health. She has worked at the CDC since 2009 and has been involved in numerous multistate outbreak investigations leading to the identification and recall of food products.
Expertise: Multistate enteric disease outbreak investigation and response, Applied/field infectious disease epidemiology, Emergency response/preparedness, Health communications during emergency response, Data management and statistical analyses
Shannon Majowicz Associate Editor
Shannon is Associate Professor in the School of Public Health and Health systems at the University of Waterloo. Her research aims include preventing foodborne and related diseases and enhancing public health practice broadly and within environmental health. She investigates burden and risks of these illnesses, interventions and focuses on food-related outcomes: infectious diseases, chronic conditions and nutrition. She explores food safety strategies that account for the multiple health outcomes associated with the production and consumption of food. Before joining SPHHS she was employed for 10 years as an epidemiologist for the Government of Canada.
Eduardo Massad Associate Editor
Eduardo is Professor of Medical Informatics in the Department of Pathology at the University of Sao Paulo. His research interests include viruses, infection, rabies, vaccinations and HIV.
Professor Massad is a medical professional with extensive experience in the field of infectious disease epidemiology and the mathematical modelling of infectious diseases. He has done a wide range of modelling work spanning Dengue, Yellow Fever, Hepatitis A, vaccine preventable diseases, parasitology, HIV and antimicrobial resistance.
Tyrone Pitt Associate Editor
NHS Blood and Transplant, UK
Dr Tyrone Pitt was until March 2009 Deputy Director of the Laboratory of HealthCare Associated Infection at the HPA Centre for Infections, Colindale, London. He is currently a Consultant Bacteriologist to the National Blood Services Microbiology Laboratory until retirement in March 2018. His primary interests include the epidemiology of bacterial infections, the microbiome and health, and microbiological issues pertaining to blood products and banked tissues.
Lucy Robertson Associate Editor
Lucy is Professor in Parasitology at the Department of Food Safety and Infection Biology within the Faculty of Veterinary Medicine. The focus of her group is directed towards epidemiology of intestinal parasites, particularly those with zoonotic potential, detection and identification in environmental matrices (especially water and food), outbreak and contamination control, viability assessment and method development, and interactions of parasites with host nutrition. She is currently a member of the BioHaz panel at the European Food Safety Authority and also Chairs the COST Action A European Network for Foodborne Parasites (EURO-FBP), where the main objective is to decrease the impact on human health from foodborne parasites (FBP) through establishing a risk-based control programme for FBP containing robust and appropriate protective strategies.
Holly Seale Associate Editor
Dr. Holly Seale is a Senior Lecturer at the School of Public Health and Community Medicine, the Program Co-Director of the Master of Infectious Diseases Intelligence course, and the Chair of the UNSW Human Research Ethics Committee (Committee B).
Holly’s research is focused on the sociological aspects of infectious diseases and infection prevention, encompassing individual, societal and organisational factors that influence compliance with infection prevention strategies/approaches/interventions developed to improve uptake. It includes pharmaceutical and non-pharmaceutical prevention strategies, consumers such as hospital/community healthcare workers, special at-risk groups (people with underlying illness, migrants/refugees), students and the general public.
She is particularly interested in the perceptions and behaviours of different groups of health professionals regarding infectious diseases, particularly VPDs and disease prevention strategies, such as immunisation. Dr Seale is also involved with a range of other research projects focused on issues around vaccination of high risk populations including migrant travellers/refugees, immunosuppressed children and other under-immunised groups.
Carlos Seas Associate Editor
Principal Investigator at CHU at the Institute of Tropical Medicine.
Dr Seas graduated in Medicine at CHU and finished his fellowship in Infectious Diseases and Tropical Medieine in 1993 at CHU. He did a Postgraduate Training in Clinical Research on Diarrheal Diseases at the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh in 1993-1994. His main clinical research is on diarrheal diseases, tuberculosis and Staphylococus aures infections. He is a member of the Infectious Disease Society of America and serves as a journal referee for: Clinical Infectious Diseases, Pediatric Infectious Diseases Journal, The American Journal of Tropical Medicine and Hygiene, PLoS ONE, PLoS Neglected Tropical Diseases, The International Journal of Tuberculosis and Lung Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, Emerging Infectious Diseases, The Journal of Infection, AIDS research and Human Retroviruses.
Benedetto Simone Associate Editor
Ben is a medical doctor and a fellow of the Royal Faculty of Public Health.
He is currently working as response expert in the Vaccine-Preventable Diseases programme at the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden.
Ben has expertise in vaccinology and public health genomics. He worked as a field epidemiologist in Public Health England, and in the industry in medical affairs, epidemiology and health economics in the vaccines area.
Tim Wreghitt Associate Editor
Until January 2011 Dr Tim Wreghitt (OBE) was Regional Microbiologist for the Health Protection Agency (HPA) in the east of England. He has been a Clinical Scientist in the HPA and an Honorary Consultant Virologist at Addenbrooke’s Hospital in Cambridge for over 30 years. Until 2011, he was responsible for public health microbiology in the east of England.
Tim currently works as a part time locum Consultant Virologist at Addenbrooke’s Hospital in Cambridge and as a Clinical Virology Consultant offering services in medicolegal expert witness reports, clinical virology, public health microbiology, medical advice on virology and commissioning pathology services.
Mark Zuckerman Associate Editor
Mark Zuckerman is a consultant medical virologist and honorary senior lecturer at the South London Specialist Virology Centre at King's College Hospital, London and King's College London Medical School.
Social Media Editor
Daniel R. Knight - Social Media Editor
Daniel Knight is an NHMRC Early Career Research Fellow at Murdoch University in Western Australia. His research is in the field of infectious diseases epidemiology and One Health, with a specialist interest in the area of Clostridium difficile Infection (CDI). Daniel’s research uses state-of-the-art microbial genomics to study the genetic factors (including antimicrobial resistance) contributing to the emergence, evolution and spread of C. difficile. Daniel has published extensively in this area and has a growing international reputation. His critical research discoveries on the interspecies transmission of C. difficile between farm animals and humans with CDI in Australia and internationally support a novel zoonotic paradigm for CDI. Daniel is a keen science communicator. He curates social media accounts for the C. difficile research community and is a communications ambassador for the Australian Society for Microbiology.
Editorial Board Statisticians
Ben Cowling Editorial Board Statistician
Professor Cowling has been the Head of the Division of Epidemiology and Biostatistics at the University of Hong Kong since 2013 where his primary research focus is infectious disease epidemiology. He is a member of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at HKU SPH. In recent years he has designed and implemented large field studies of influenza transmission in the community and the effectiveness and impact of control measures including vaccination. His research aims to integrate information on transmission dynamics at the individual level, with disease burden, severity and dynamics at the population level. His latest research has focused on the modes of respiratory virus transmission, influenza vaccination effectiveness, immunity to infections, and the potential causes and implications of interference between respiratory viruses. He has strong links with China CDC, and the NIGMS-funded Harvard Center for Communicable Disease Dynamics. Ben is a fellow of the Royal Statistical Society and a Fellow of the UK Faculty of Public Health.
Naor Bar-Zeev Editorial Board Statistician
Naor is a consultant paediatrician, infectious diseases physician and statistical epidemiologist. His research focuses on vaccine clinical trails and effectiveness studies; and surveillance systems for respiratory and diarrhoeal disease and mortality among children in Malawi. Naor is principally interested in evaluating public health impact, effectiveness and the cost-effectiveness of vaccines in actual use in high disease burden settings, in order to optimise the benefit of existing vaccines and to evauate novel vaccines and vaccination strategies. He is a Fellow of the Royal Australasian College of Physicians, Fellow of the Australasian College of Tropical Medicine and Fellow of the Royal Statistical Society, and is an Accredited Statistician with the Statistical Society of Australia.
David J. Price Editorial Board Statistician
David is a Research Fellow (Biostatistics) at the Centre for Epidemiology and Biostatistics, University of Melbourne, and the Peter Doherty Institute for Infection and Immunity. David is a statistician and mathematical modeller with a research focus on the optimal design of experiments, particularly those concerning infectious diseases, and on the modelling of within-host bacterial infection dynamics.
Prior to joining the University of Melbourne, David was a Research Associate in the Disease Dynamics Unit at the University of Cambridge, where he aided in the development of a computational package to facilitate the optimal design and statistical analysis of laboratory experiments in microbiology and infectious disease research, and provided statistical support to clinical veterinary researchers.
Fiona Warburton Editorial Board Statistician
Fiona is currently working as a statistician in the Dental Institute at Kings College London. Previously she has worked as a Statistician at Public Health England where she was mainly involved in the analysis of studies into Influenza, including mid-season and end of season influenza Vaccine Effectiveness estimates for the UK. She has also worked as a statistician in the NHS and in various university medical schools.
Preben Aavitsland Editorial Board Member
Preben is senior consultant at the Norwegian Institute of Public Health, municipal medical officer in Arendal city, and professor of infectious disease prevention and control at the University of Oslo, Norway. He has previously served at the Advisory Forum of the Europen Centre for Disease prevention and Control (ECDC). He was a member of the WHO International Health Regulations Review Committees after the 2009 influenza pandemic and the 2014-15 Ebola epidemic. His recent published work has covered topics such as pandemic vaccination strategies, influenza, surveillance data, chlamydia, post-surgery infection risks and policy decisions relating to infection and epidemiology.
David J. Allen Editorial Board Member
David is Assistant Professor in Virology at the London School of Hygiene & Tropical Medicine, and prior to this was Unit Head at the Enteric Virus Unit, Virus Reference Department, at Public Health England. His current research interests are primarily in enteric virus infections, using classical and molecular virology approaches and sequencing technologies to understand the determinants of these viruses that drive their highly dynamic epidemiology.
Sir Roy M. Anderson Editorial Board Member
Sir Roy is Professor of Infectious Disease Epidemiology in the School of Public Health, Imperial College London and Director of the London Centre for Neglected Tropical Disease Research.
Sir Roy served as Director of the Wellcome Centre for Parasite Infections (at Imperial College London) and Director of the Wellcome Centre for the Epidemiology of Infectious Disease (at the University of Oxford). He is the author of over 450 scientific articles and has sat on numerous government and international agency committees advising on public health and disease control including the World Health Organisation and UNAIDS. He is a non-executive director of GlaxoSmithKline.
Sir Roy was elected Fellow of the Royal Society in 1986, a Founding Fellow of the Academy of Medical Sciences in 1998, and a Foreign Associate Member of the National Academy of Medicine at the US National Academy of Sciences in 1999. He was knighted in the 2006 Queen's Birthday Honors.
Timothy Brewer Editorial Board Member
Dr Brewer is Professor of Medicine and Epidemiology at the University of California, Los Angeles. His research interests include using analytic methods to optimize the control of infectious diseases in populations, particularly the prevention and control of multiple drug-resistant tuberculosis, global risk factors for emerging diseases and the improvement of worldwide outbreak surveillance programs. He has served in advisory roles and/or review panels for the World Health Organization, the National Institutes of Health, the Canadian Institutes of Health Research and the US Centers for Disease Control and Prevention among others. Dr. Brewer previously was the Program Director for the International Society for Infectious Diseases, and a past Chair of the Board of Directors for the Consortium of Universities for Global Health.
Mike Catchpole Editorial Board Member
Professor Catchpole is Chief Scientist at the European Centre of Disease Prevention and Control. He has worked in infectious disease epidemiology and response at the national and international level since 1991. He was the Director of Public Health England’s national Centre for Infectious Disease Surveillance and Control. He was also the clinical lead for the Tuberculosis National Knowledge Service. His primary research interests have included HIV and other sexually transmitted infections, the wider health effects of major incidents, and public health information systems development. He has academic appointments at Imperial College and at City University, London. Amongst his other publications, Mike contributed to the 2013 book on antimicrobial resistance The Drugs Don't Work: A Global Threat. Prior to joining ECDC as Chief Scientist in autumn 2014, he was the UK representative on ECDC’s Advisory Forum, and was chairman of the EPIET Steering Committee for six years.
Jan Clement Editorial Board Member
Jan, a nephrologist by formation, was the founder in 1985 of the Belgian Zoonoses Workgroup, sponsored by NATO, which performed research in the field of "new" zoonotic infections being a potential threat to certain professions working in open field conditions i.e. hantavirus, Lyme disease, tick- borne encephalitis (TBE), leptospirosis, etc.. These activities lead him to the foundation in 1990 of the Belgian National Reference Centre (NRC) for Hantavirus Infections, and to a function as Senior Research Associate at the Laboratory of Epidemiogical and Clinical Virology, University of Leuven, Belgium. Dr Clement reported the first grand scale sero-epidemiological study on hantaviruses in Belgium (1985), and the first serological confirmation of clinical hantavirus cases in Germany (1987), the Netherlands (1989), the New World (Recife, Brazil 1993), Ireland (1994), and India (2006). Jan is author or co-author of 155 papers and of 29 chapters in medical books or Proceedings and reviews for a large number of distinguished journals, including The Lancet, Emerging Infectious Diseases and Vector-borne and Zoonotic Diseases.
Michael David Editorial Board Member
Dr David was an undergraduate at Amherst College. He then studied medicine at Yale University (M.D., 2001) and Russian history at the University of Chicago (Ph.D., 2007) with a dissertation on the history of tuberculosis control in Russia, 1900-1941. He completed the Robert Wood Johnson Clinical Scholars' Program (2004-6) and a Fellowship in clinical infectious diseases at the University of Chicago (2006-9). He studied biostatistics and epidemiology at Chicago (M.S., 2007) after his Yale residency in internal medicine (2001-4). Since 2004, he has studied the epidemiology of Staphylococcus aureus in the U.S., including studies in jails, rural Alaska, hospitals, households, and in cystic fibrosis patients, particularly with a focus on community-associated (CA-) methicillin-resistant S. aureus (MRSA) infections. He is interested in all aspects of the molecular and clinical epidemiology of S. aureus colonization and infection, the underpinnings of the fitness of CA-MRSA strains, hospital infection control, and the history of infectious diseases.
Christopher Fairley Editorial Board Member
Christopher Fairley is Director of the Melbourne Sexual Health Centre at Alfred Health and Professor of Public Health at Monash University. He holds three specialist medical fellowships from the College of Physicians (Infectious Diseases), Faculty of Public Health and Chapter of Sexual Health Medicine. He is an editor of the Journal ‘Sexual Health’. His principle research interests are the public health control of sexually transmitted diseases and the effectiveness of clinical services. He has supervised 27 doctoral students to completion. He has 640 review journal publications and sits on the boards of IUSTI and ISSTDR.
David Fisman Editorial Board Member
David is a Professor and Acting Chair in the Division of Epidemiology at the University of Toronto. Professor Fisman is a Full Member of the School of Graduate Studies and is cross-appointed to the Department of Medicine, Faculty of Medicine, University of Toronto. He is an attending physician in Infectious Diseases at the University Health Network. His current research interests lie at the intersection of infectious disease modelling and health economics, and in the relationship between environmental change and infectious disease incidence.
Anthony Fooks Editorial Board Member
Dr Fooks is the Lead Scientist for International Development at the Animal and Plant Health Agency (APHA) in the UK. His research interests include pathogens at the veterinary / human interface with particular attention to the evolution / epidemiology, infection dynamics and host immunity of zoonotic RNA viruses. He has published more than 300 publications in virology.
In 2002, Dr Fooks was appointed a director of a World Health Organisation Communicable Disease Surveillance and Response Collaborating Centre and in 2006 he was designated an OIE expert for rabies. He holds an Honorary Visiting Professorship (Virology) in the Department of Clinical Infection, Microbiology and Immunology, Institute of Infection & Global Health at the University of Liverpool and also an Honorary Visiting Professorship (Viral Zoonoses) at St George’s University of London in the UK.
Susan Hahné Editorial Board Member
Susan is a Consultant Epidemiologist at the National Institute for Public Health and the Environment (RIVM) in Bilthoven, the Netherlands. She heads the department for Early warning and Surveillance at the RIVM’s Centre for Infectious Disease Control.
Susan trained as a medical doctor and health scientist, and became a public health specialist (Fellow of the Faculty of Public Health (UK) and field epidemiologist (EPIET). She completed a PhD on the epidemiology and control through vaccination of hepatitis B. She contributed to over 100 peer-reviewed publications and three book chapters. Susan is a host-site supervisor for EPIET fellows. Her research interests include the epidemiology and control of vaccine preventable diseases, surveillance and outbreak investigations.
Sherilee Harper Editorial Board Member
Sherilee Harper is an Assistant Professor in the Department of Population Medicine at the University of Guelph. She uses ecosystem approaches to health research to examine Indigenous environmental health outcomes in the context of climate change, and she collaborates with Indigenous partners to prioritise climate-related health actions, planning, interventions, and research.
Craig W. Hedberg Editorial Board Member
Craig's research focuses on foodborne illness and infectious disease outbreaks. He has worked on several national groups to prevent foodborne illness, and serves as academic lead for Minnesota's Integrated Food Safety Center of Excellence. His work also focuses on surveillance, outbreak investigation, and public health preparedness. Prior to academia, he was the supervisor of the Vectorborne and Zoonotic Diseases Unit at the Minnesota Department of Health.
He has won the Outstanding Public Health Impact Award at the School of Public Health in 2016 and has professional associations with the Council of State and Territorial Epidemiologists, Minnesota Environmental Health Association and the International Association for Food Protection.
David Heymann Editorial Board Member
David Heymann is currently Professor of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine; head of the Centre on Global Health Security at Chatham House, London; and chairman of Public Health England, UK.
Previously he was the World Health Organization's assistant director-general for Health Security and Environment, and representative of the director-general for polio eradication; prior to that he was executive director of the WHO cluster of Communicable diseases. Before joining WHO in 1989, Heymann spent 2 years in India 13 years in Africa working on research issues in tropical and communicable diseases and smallpox eradication, on secondment from the US Centers for Disease Control.
Yvan Hutin Editorial Board Member
Dr J-F. Hutin is a Technical Officer in charge of Strategic Information at the Global Hepatitis Programme (GHP) of the World Health Organization (WHO) Headquarters in Geneva, Switzerland. After a MD training and a residency in hepato-gastroenterology, he joined the Epidemic Intelligence Service (EIS) of the United States’ Centers for Disease Control and Prevention (CDC) and completed a PhD in epidemiology at the University of Basel. As part of his public health career, he has worked in Burkina Faso, Uganda, India, China and Sweden. His areas of expertise include epidemiology and prevention of viral hepatitis and Field Epidemiology Training Programmes (FETPs).
Chikwe Ihekweazu Editorial Board Member
Dr. Chikwe Ihekweazu is the Director General of the Nigeria Centre for Disease Control (NCDC) and was until January 2018, the Acting Director of the Regional Centre for Disease Control for West Africa. Dr Ihekweazu trained as an infectious disease epidemiologist and has over 20 years’ experience working in senior public health and leadership positions in several National Public Health Institutes, including the South African National Institute for Communicable Diseases (NICD), the UK's Health Protection Agency, and Germany’s Robert Koch Institute (RKI). Dr Ihekweazu has led several short-term engagements for WHO, mainly in response to major infectious disease outbreaks around the world.
Michael Lynch Editorial Board Member
U.S. Centers for Disease Control and Prevention, USA
Michael is a Medical Epidemiologist in the Global Immunization Division at the US Centers for Disease Control. From 2008-2017 he served with the CDC Malaria Branch in several capacities, including 4 years detailed to the Global Malaria Programme at WHO Headquarters in Geneva, Switzerland and as a regional coordinator for the US President’s Malaria Initiative. Mike began his career with CDC in 2002 as an Epidemic Intelligence Service officer, and continued as a staff epidemiologist from 2004 to 2008, with the Enteric Diseases Epidemiology Branch, where he coordinated national foodborne disease outbreak response and conducted field investigations of enteric infections. Before joining CDC, he practiced internal medicine for 10 years in Boston, Massachusetts.
Raina MacIntyre Editorial Board Member
Professor MacIntyre is Professor of Global Biosecurity. Her work falls under 4 areas: Personal protective equipment, vaccinology, epidemic response/emerging infectious diseases and biosecurity.
She is best known for research in the detailed understanding of the transmission dynamics and prevention of infectious diseases. Her research includes personal protective equipment and adult vaccination, focussing on the elderly, including influenza, pneumococcal disease, HPV and herpes zoster. She has also done research on using risk-analysis methods for bioterrorism and for analysing emerging infectious diseases outbreaks such as MERS-CoV. She is also interested in the ethics of medicine; specifically in dual-use research of concern.
Raina leads a NHMRC Centre for Research Excellence in Epidemic Response, ISER which addresses gaps in global systems for epidemic response and biosecurity. She has extensive field outbreak investigation experience, is on the Global Accreditation Board of TEPHINET, and has extensive experience in shoe-leather epidemiology and outbreak investigation. She has adjunct appointments at ASU, and at SJTU School of Medicine.
Thomas J. Marrie Editorial Board Member
Thomas became the twelfth Dean of the Medicine at Dalhousie University in 2009. Previously, he was the Dean of the University of Alberta’s Faculty of Medicine and Dentistry. Dr. Marrie had a 22 year career at the Faculty of Medicine, Dalhousie University, where he founded the Division of Infectious Diseases. His leadership on national committees and boards includes terms as associate editor of “Physical Signs” for the American Journal of Medicine, president of the CAPM
Thomas is a Member of the Order of Canada, Fellow of the Royal Society of Canada and Fellow of the CAHS. He has won a Master Clinician Lecturer Award (Department of Medicine, Dalhousie University), a Lifetime Achievement Award (Association of Medical Microbiology and Infectious Diseases of Canada), and an honorary doctorate (University of Mediterranean, Marseille). Dr. Marrie completed his term as Dean of Medicine, Dalhousie University in 2015.
Jodie McVernon Editorial Board Member
Professor McVernon is a Monash University Medical Graduate with subspecialty training in Paediatrics, Public Health and Vaccinology. She has extensive expertise in clinical vaccine trials, epidemiologic studies and mathematical modelling of infectious diseases, gained at the University of Oxford, Health Protection Agency London and University of Melbourne. She is Professor and Director of Doherty Epidemiology at the Peter Doherty Institute for Infection and Immunity, and heads the Modelling and Simulation Group within the Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health. Her research group uses mathematical and computational models to synthesise insights gained from basic biology, epidemiological data and sociological research. These models advance understanding of the observed epidemiology of influenza and other infections in populations and inform predictions of the likely success of interventions to limit transmission and disease.
Elizabeth Miller Editorial Board Member
To date, Professor Miller has authored over 250 peer reviewed publications relating to vaccines and immunization programmes. She has been involved with trials of acellular pertussis, MMR, Hib, meningococcal C vaccines and more recently with the new pneumococcal and HPV vaccines as well as A/H1N1 pandemic vaccines. Her other research interests include seroepidemiology and mathematical modeling, vaccine safety studies and viral infections in pregnancy.
Philip Monk Editorial Board Member
Dr Monk trained and worked as a GP before training in Public Health and becoming a consultant in 1992. He led the investigation into a cluster of vCJD which announced its conclusions in 2001. He also led the investigation and management of a large school based outbreak of TB in 2001. He was a member of the NICE Guideline Development Group for CG 102 meningitis (bacterial) and meningococcal septicaemia in under 16s. He has been involved in the translation of whole genome sequencing for TB into routine use in public health in England.
Philip P. Mortimer Editorial Board Member
Philip is the former director of the Virus Reference Division of the Central Public Health Laboratory in Colindale.
Kristy Murray Editorial Board Member
Kristy is the Assoc. Vice-Chair for Research for the Dept of Pediatrics, a tenured Assoc Prof in Pediatric Tropical Medicine, and one of the founding faculty of the National School of Tropical Medicine, where she serves as an Assistant Dean. Her research over the past 20 years has been focused on vector-borne and zoonotic diseases, including West Nile, dengue, Chagas, and rabies. In 2013, she received the Bailey Ashford Medal from ASTMH for her work in tropical medicine.
Gopinath Balakrish Nair Editorial Board Member
Dr Nair currently works in the Research, Policy and Cooperation Unit of WHO South-east Asia in New Delhi. His previous roles included the Executive Director of the Translational Health Science Technology Institute (THSTI) and the Director of the National Institute of Cholera and Enteric Diseases (NICED). After leaving NICED in 2000, he spent 7 years working at the International Centre for Diarrhoeal Diseases in Dhaka as Director of the Laboratory Science Division.
Dr. Nair has authored over 500 research papers, primarily focussing on enteric pathogens such as Vibrio cholerae, the causative agent of cholera. More recently he has been researching the Human Microbiome with particular interest in the human gut microbiota and was instrumental in creating the Centre for Human Microbial Ecology at THSTI.
Dr. Nair is a Fellow of all the major National Academies of India, TWAS and the American Academy of Microbiology. Additionally he is Foreign Associate of the US National Academy of Sciences and Member of Leopoldina.
Samson Okello Editorial Board Member
Dr. Samson Okello is a clinical lecturer and epidemiologist at the Department of Internal Medicine at Mbarara University of Science and Technology, Uganda. His research interests include interaction between HIV and cardiovascular disease, microbial etiology of upper GI cancers, and hepatitis in key populations.
Pablo Okhuysen Editorial Board Member
Professor Okhuysen has over 20 years’ experience in the study of enteric infectious diseases. He has conducted clinical and translational research in subjects with norovirus infection, Traveler’s diarrhea, cryptosporidiosis and HIV and received the Oswald Avery Award for Early Accomplishment from the Infectious Diseases Society of America in 2007. In 2013 he joined the MD Anderson Cancer Center and established a new laboratory dedicated to the study of enteropathogens in immunocompromised and cancer patients. He is an active member of the NIH funded Texas Medical Center Digestive Diseases Center.
Katharina Staerk Editorial Board Member
Professor Staerk graduated as a veterinarian from Zurich Veterinary School and obtained post-graduate qualifications from the Federal Institute of Technology (Switzerland) and Massey University (New Zealand). Over the last two decades, she has conducted applied research on infectious diseases and zoonoses as well as risk analysis, surveillance and animal health decision making in relation to animal-derived food. She has worked in diverse environments including government, private industry and academia in several countries. Katharina has repeatedly served on international working groups and expert panels.
James Stuart Editorial Board Member
London School of Hygiene and Tropical Medicine
Dr Stuart is an honorary professor at the University of Bristol, UK, and honorary senior lecturer at the London School of Hygiene and Tropical Medicine, UK.
After qualifying in medicine in 1974, James worked for ten years as a clinical doctor in the UK and rural South Africa before specialising in public health and epidemiology of infectious diseases, particularly meningococcal disease. He has been involved in the investigation and control of outbreaks of meningococcal disease in the UK and international level, and has published extensively on the epidemiology of meningococcal disease and carriage.
In recent years he was involved in a major research project into meningococcal carriage during the introduction of a conjugate serogroup A vaccine rolled out across the meningitis belt of Africa. He has assisted the WHO to revise outbreak response guidelines in the meningitis belt, and is helping develop a strategy for use of Ebola vaccines in outbreaks of Ebola Virus Disease.
Robert Tauxe Editorial Board Member
National Center for Emerging and Zoonotic Infectious Diseases, USA
Robert is the Director in the Division of Foodborne, Waterborne and Environmental Diseases at the Natonal Center for Emerging and Zoonotic Infectious Diseases. The Division monitors the frequency of these infections in the US, investigates outbreaks and develops strategies to reduce the disease disability and deaths that they cause. He is interested in bacterial enteric diseases, epidemiology and pathogenesis of infectious diseases, epidemiologic and clinical consequences of bacterial genetic exchange, antimicrobial use and resistance to antimicrobial agents, and teaching epidemiologic methods.
Robert has memberships with the American Epidemiology Society, the American College of Physicians and the American Society for Microbiology and the American Academy of Microbiology. He is a Fellow of the Infectious Diseases Society of America and member of the National Advisory Committee on Microbial Criteria for Foods.
Alexandre P. Zavascki Editorial Board Member
Alexandre is a Professor of Infectious Diseases from the Medical School and is the head of Infectious Diseases Service of its affiliated teaching hospital. He mostly works with hospital-acquired and infections in transplant patients. His research field include the epidemiology of bacterial resistance as well as clinical, pharmacological and microbiological studies related to the treatment of multidrug-resistant pathogens, notably, Gram-negative bacteria. He has been acting as an advisor on bacterial resistance for the Brazilian Society of Infectious Diseases. He is also the current Clinical Coordinator of the Brazilian Committee on Antimicrobial Susceptibility Testing.
Guoqiang Zhu Editorial Board Member
Guoqiang Zhu is a Professor within the College of Veterinary Medicine. His research interests include Veterinary Microbiology and Microbial Disease, Animal Pathogen and Molecular Pathogenesis, Interaction between microorganisms and host cells (particularly in bacterial adhesins-related field and E-coli and adhesion vaccine).